Stability and compatibility of methylprednisolone sodium succinate and cimetidine hydrochloride in 5% dextrose injection
- PMID: 1858803
Stability and compatibility of methylprednisolone sodium succinate and cimetidine hydrochloride in 5% dextrose injection
Abstract
The stability and compatibility of methylprednisolone sodium succinate in admixtures with cimetidine hydrochloride in 5% dextrose injection were determined. Admixtures containing methylprednisolone sodium succinate, in concentrations equivalent to methylprednisolone 0.4 or 1.25 mg/mL, and cimetidine 3 mg/mL (as the hydrochloride salt) were prepared in 5% dextrose injection 100 mL. Control solutions containing each drug alone at the same concentrations were also prepared. The admixtures were prepared in triplicate and were kept in polyvinyl chloride infusion containers at controlled room temperature (24 degrees C). Immediately after mixing and at 2, 4, 8, 12, and 24 hours, samples were removed and visually inspected, measured for pH, and assayed by stability-indicating high-performance liquid chromatography to determine the concentrations of methylprednisolone 21-succinate ester and cimetidine. No visual evidence of incompatibility was noted either with the unaided eye or a microscope. No substantial changes in pH occurred over the study period. The addition of cimetidine decreased the pH of the methylprednisolone sodium succinate control solutions from about 7.3 to about 5.6. The concentrations of methylprednisolone 21-succinate ester and cimetidine in both test and control solutions did not change significantly over the 24-hour study period. Methylprednisolone sodium succinate, in concentrations equivalent to methylprednisolone 0.4 and 1.25 mg/mL, was chemically stable and visually compatible in admixtures with cimetidine 3 mg/mL (as the hydrochloride salt) in 5% dextrose injection 100 mL at 24 degrees C for 24 hours.
Similar articles
-
Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures.Am J Hosp Pharm. 1986 Jun;43(6):1482-5. Am J Hosp Pharm. 1986. PMID: 3524206
-
Compatibility of premixed theophylline and methylprednisolone sodium succinate intravenous admixtures.Am J Hosp Pharm. 1987 Jul;44(7):1620-4. Am J Hosp Pharm. 1987. PMID: 3307397
-
Compatibility of cefoperazone sodium and cimetidine hydrochloride in 5% dextrose injection.Am J Hosp Pharm. 1991 Jan;48(1):111-3. Am J Hosp Pharm. 1991. PMID: 2000866
-
Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs.Am J Health Syst Pharm. 2001 Jul 1;58(13):1218-23. doi: 10.1093/ajhp/58.13.1218. Am J Health Syst Pharm. 2001. PMID: 11449879 Review.
-
[In vitro drug interactions and their importance in anesthesiologic practice].Anasthesiol Intensivmed Notfallmed Schmerzther. 1991 Oct;26(6):315-20. doi: 10.1055/s-2007-1000591. Anasthesiol Intensivmed Notfallmed Schmerzther. 1991. PMID: 1751653 Review. German.
Cited by
-
Compatibility and stability of methylprednisolone sodium succinate and granisetron hydrochloride in 0.9% sodium chloride solution.Medicine (Baltimore). 2022 Jul 15;101(28):e29674. doi: 10.1097/MD.0000000000029674. Medicine (Baltimore). 2022. PMID: 35839031 Free PMC article.